logo
Plus   Neg
Share
Email

Evonik Industries Q2 Profit Halves On Weak Demand; Confirms FY20 Outlook - Quick Facts

Specialty chemicals company Evonik Industries AG (EVK.DE) reported Tuesday that its second-quarter net income halved to 114 million euros from last year's 228 million euros.

Adjusted net income was 160 million euros, compared to 227 million euros a year ago. Adjusted earnings per share declined to 0.34 euro from 0.49 euro last year.

Adjusted EBITDA fell 19 percent from last year to 456 million euros.

Sales declined 14 percent to 2.83 billion euros from 3.31 billion euros in the prior year. Sales and earnings in the second quarter decreased due to significantly weaker demand in some markets.

Looking ahead for fiscal 2020, the company continues to expect sales of between 11.5 billion euros and 13.0 billion euros, and adjusted EBITDA of between 1.7 billion euros and 2.1 billion euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030. The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020.
Follow RTT